- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT01819324
A Lifestyle Intervention for Breast Cancer Survivors (TTMI)
Targeting the Teachable Moment: A Lifestyle Intervention for Breast Cancer Survivors
- The purpose of the study is to test the effectiveness of a new mail-based intervention for breast cancer survivors compared with standard lifestyle management and no-treatment.
- This intervention addresses both lifestyle factors such as dietary and physical activities and psychological issues specific to breast cancer survivors to improve healthy behaviors.
Studieoversikt
Status
Forhold
Intervensjon / Behandling
Detaljert beskrivelse
Participants will be assigned randomly to one of three groups: 1) newly developed mail-based intervention (Targeting the Teachable Moment Intervention; TTMI), 2) standard Lifestyle Intervention (SLM), and 3) usual care. Both TTMI and SLM focus on health behaviors, however TTMI additionally addresses psychosocial issues specific to breast cancer survivors.
All participants will complete questionnaires at the time they start the study, the end of the 4 months, and 3 months later for a follow-up.
If participants are assigned to any of the intervention group, they will receive materials every other week for 4 months. If participants are assigned to the usual care group, they will receive the same materials as the standard lifestyle intervention et the end of the 7 months.
Studietype
Registrering (Faktiske)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiesteder
-
-
Connecticut
-
Storrs, Connecticut, Forente stater, 06269
- University of Connecticut
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- First diagnosed with breast cancer in the past 1.5 years
- stage 0~2 breast cancer
- no prior adjuvant treatment for another cancer
- Can read and write English
- Are not participating in other health behavior research right now
Exclusion Criteria:
- apparent serious mental disturbance
- male breast cancer survivors
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
---|---|
Eksperimentell: Targeting the Teachable Moment
Receiving Targeting the Teachable Moment Intervention materials (focusing on health behaviors and issues specific to breast cancer survivors) every other week for 4 months
|
TTMI material (every other week for 4 months)
Andre navn:
|
Aktiv komparator: Standardized Lifestyle Management
Receiving Standardized Lifestyle Management materials (focusing mostly on health behaviors) every other week for 4 months
|
SLM material (every other week for 4 months)
Andre navn:
|
Ingen inngripen: Usual Care
Receiving SLM materials at the end of the 7 months
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
Changes in eating habits measured by the National Cancer Institute Quick Food Scan
Tidsramme: Meaured at baseline, 4 months, and 7 months
|
Diet habits (amount of fat and fruit/vegetable uptake) will be assessed at 3 times: at baseline, at the end of the 4 months, and at the end of 7 months.
|
Meaured at baseline, 4 months, and 7 months
|
Changes in physical activity measured by the Paffenbarger physical activity questionnaire
Tidsramme: Meaured at baseline, 4 months, and 7 months
|
Frequency and amount of time for physical exercise will be measured at 3 times: at baseline, at the end of 4 months, and at the end of 7 months.
|
Meaured at baseline, 4 months, and 7 months
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
Changes in coping strategies measured by the Brief COPE
Tidsramme: Measured at baseline, 4 months, and 7 months
|
Coping strategies (e.g., problem-focused coping, emotional approach coping) will be assessed at 3 times: at baseline, at the end of the 4 months, and at the end of 7 months.
|
Measured at baseline, 4 months, and 7 months
|
Changes in Self-efficacy measured by the General Self-Efficacy Scale
Tidsramme: Measured at baseline, 4 months, and 7 months
|
A general sense of perceived self-efficacy will be measured at 3 times: at the baseline, at the end of 4 months, and at the end of 7 months
|
Measured at baseline, 4 months, and 7 months
|
Changes in social support measured by the Interpersonal Support Evaluation List (ISEL)
Tidsramme: Measured at baseline, 4 months, and 7 months
|
Social support will be measured at 3 times: at baseline, at the end of 4 months, and at the end of 7 months
|
Measured at baseline, 4 months, and 7 months
|
Changes in life meaning measured by the Meaning in Life Questionnaire (MLQ)
Tidsramme: Measured at baseline, 4 months, and 7 months
|
Presence of Meaning and Search for Meaning will be measured at 3 times: at baseline, at the end of 4 months, and at the end of 7 months.
|
Measured at baseline, 4 months, and 7 months
|
Andre resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
Feedback of each module
Tidsramme: up to 4 months
|
usefulness of each module (e.g., whether each intervention is helpful or not) will be assessed at each mailing (for eight times) for 4 months.
|
up to 4 months
|
Samarbeidspartnere og etterforskere
Sponsor
Samarbeidspartnere
Etterforskere
- Hovedetterforsker: Crystal L. Park, Ph.D, University of Connecticut
Studierekorddatoer
Studer hoveddatoer
Studiestart
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Anslag)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Anslag)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- Park003382HE
- 5R21CA152129-02 (U.S. NIH-stipend/kontrakt)
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .
Kliniske studier på Brystkreft
-
Tianjin Medical University Cancer Institute and...Guangxi Medical University; Sun Yat-sen University; Chinese PLA General Hospital og andre samarbeidspartnereFullførtThe Clinical Application Guide of Conebeam Breast CTKina
-
Novartis PharmaceuticalsFullførtMetastatisk brystkreft (MBC) | Locally Advance Breast Cancer (LABC)Storbritannia, Spania
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.UkjentHR-positiv, HER2-negativ og PIK3CA Mutation Advanced Breast CancerKina
-
Emory UniversityNational Cancer Institute (NCI)TilbaketrukketPrognostisk stadium IV brystkreft AJCC v8 | Metastatisk malign neoplasma i hjernen | Metastatisk brystkarsinom | Anatomic Stage IV Breast Cancer American Joint Committee on Cancer (AJCC) v8
-
NRG OncologyNational Cancer Institute (NCI)Aktiv, ikke rekrutterendeAnatomisk stadium IV brystkreft AJCC v8 | Prognostisk stadium IV brystkreft AJCC v8 | Metastatisk malign neoplasma i beinet | Metastatisk malign neoplasma i lymfeknutene | Metastatisk malign neoplasma i leveren | Metastatisk brystkarsinom | Metastatisk malign neoplasma i lungen | Metastatisk malign neoplasma... og andre forholdForente stater, Canada, Saudi-Arabia, Korea, Republikken
Kliniske studier på Targeting the Teachable Moment
-
DanceStream ProjectsAlzheimer's AssociationRekrutteringDemens | Alzheimers sykdom | Mild kognitiv svikt | Lewy kroppssykdom | Frontotemporal demens | Vaskulær demensForente stater